yr 〜
yr

Search results 2

Pertuzumab, trastuzumab and eribulin mesylate therapy for previously treated advanced HER2-positive breast cancer: a feasibility study with analysis of biomarkers

Pertuzumab, trastuzumab and eribulin mesylate therapy for previously treated advanced HER2-positive breast cancer: a feasibility study with analysis of biomarkers
Digital博士論文障害者向け資料あり
Tono, Yasutaka三重大学2018-03-26
National Diet Library
  • Subject HeadingHER2-positive breast cancer eribulin mesylate pertuzumab trastuzumab
  • Note (General)...combination of pertuzumab, trastuzumab a......ility study of pertuzumab, trastuzumab and eribulin mes...

Pertuzumab, trastuzumab and eribulin mesylate therapy for previously treated advanced HER2-positive breast cancer: a feasibility study with analysis of biomarkers

Pertuzumab, trastuzumab and eribulin mesylate therapy for previously treated advanced HER2-positive breast cancer: a feasibility study with analysis of biomarkers
Digital博士論文
戸野, 泰孝三重大学2018-03-26
Available onlineOther Libraries in Japan
  • Summary, etc....combination of pertuzumab, trastuzumab a......ility study of pertuzumab, trastuzumab and eribulin mes...
  • Subject HeadingHER2-positive breast cancer eribulin mesylate pertuzumab trastuzumab

Reached to the end of result.